QSS
MYOK

Quantitative Systematic Strategies’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Quantitative Systematic Strategies’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,178
Closed -$546K – 746
2018
Q4 		$546K Buy
+11,178
New +$615K 0.12% 252

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Quantitative Systematic Strategies's MYOK Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2019, closing a stake of 11,178 shares — an estimated $546K sold.

Quantitative Systematic Strategies first reported a position in MYOK in Q4 2018 and held it in 1 quarter. The position peaked at $546K in Q4 2018. 169 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,178 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $546K.
  • Quantitative Systematic Strategies first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's MyoKardia, Inc. Common Stock position peaked at $546K in Q4 2018.
  • 169 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.